TDMS Study 97013-09 Pathology Tables
NTP Experiment-Test: 97013-09 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03 Study Type: SUBCHRON 26-WEEK WATER DISINFECTION MODEL (SODIUM BROMATE) Date: 06/18/04 Route: DOSED WATER Time: 11:02:42 FINAL #1 MICE Facility: Battelle Columbus Laboratory Chemical CAS #: 7789-38-0 Lock Date: 07/30/01 Cage Range: All Reasons For Removal: All Removal Date Range: All Treatment Groups: Include 001 0 MG/L Include 002 0 MG/L Include 003 80 MG/L Include 004 80 MG/L Include 005 400 MG/L Include 006 400 MG/L Include 007 800 MG/L Include 008 800 MG/L a Number of animals examined microscopically at site and number of animals with lesion Page 1 NTP Experiment-Test: 97013-09 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03 Study Type: SUBCHRON 26-WEEK WATER DISINFECTION MODEL (SODIUM BROMATE) Date: 06/18/04 Route: DOSED WATER Time: 11:02:42 ____________________________________________________________________________________________________________________________________ TGAC (FVB/N) HEMIZYGOUS FEMALE 0 MG/L 80 MG/L 400 MG/L 800 MG/L ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially In Study 15 15 15 15 Early Deaths Natural Death 3 5 5 3 Moribund Sacrifice 2 1 Survivors Terminal Sacrifice 10 9 10 12 Animals Examined Microscopically 15 15 15 15 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM Liver (15) (15) (15) (15) Hematopoietic Cell Proliferation 1 (7%) 1 (7%) 1 (7%) Inflammation, Chronic Active 11 (73%) 9 (60%) 10 (67%) 12 (80%) Necrosis 1 (7%) 1 (7%) Hepatocyte, Vacuolization Cytoplasmic 5 (33%) 5 (33%) 5 (33%) Mesentery (1) Fat, Congestion 1 (100%) Fat, Hemorrhage 1 (100%) Stomach, Forestomach (15) (15) (15) (15) Epithelium, Hyperkeratosis 4 (27%) 3 (20%) 3 (20%) 7 (47%) Epithelium, Hyperplasia 5 (33%) 3 (20%) 3 (20%) 8 (53%) Tooth (1) (3) (2) (4) Inflammation, Chronic Active 1 (33%) ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM Blood Vessel (1) Inflammation, Chronic 1 (100%) Necrosis, Fibrinoid 1 (100%) ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM Adrenal Cortex (15) (15) (15) (15) Mineralization 1 (7%) Necrosis 1 (7%) Subcapsular, Hyperplasia 4 (27%) 6 (40%) 2 (13%) 2 (13%) Pituitary Gland (15) (15) (15) (15) Pars Distalis, Cyst 1 (7%) 2 (13%) a Number of animals examined microscopically at site and number of animals with lesion Page 2 NTP Experiment-Test: 97013-09 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03 Study Type: SUBCHRON 26-WEEK WATER DISINFECTION MODEL (SODIUM BROMATE) Date: 06/18/04 Route: DOSED WATER Time: 11:02:42 ____________________________________________________________________________________________________________________________________ TGAC (FVB/N) HEMIZYGOUS FEMALE 0 MG/L 80 MG/L 400 MG/L 800 MG/L ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM - CONT Pars Distalis, Hypertrophy 6 (40%) Thyroid Gland (15) (13) (13) (15) Infiltration Cellular, Lymphocyte 5 (38%) 11 (73%) Inflammation, Chronic Active 1 (7%) Follicle, Depletion Secretory 7 (47%) 7 (54%) 11 (85%) 14 (93%) Follicular Cell, Hypertrophy 2 (13%) 2 (15%) 11 (85%) 13 (87%) ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM Ovary (15) (15) (14) (15) Cyst 1 (7%) 1 (7%) Mineralization 1 (7%) Pigmentation, Hemosiderin 1 (7%) 1 (7%) Uterus (15) (15) (15) (15) Endometrium, Hyperplasia, Cystic 4 (27%) 7 (47%) 6 (40%) 3 (20%) ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM Lymph Node, Mandibular (15) (15) (15) (15) Hematopoietic Cell Proliferation 1 (7%) Hyperplasia, Lymphoid 4 (27%) 2 (13%) 5 (33%) Necrosis, Lymphoid 1 (7%) Lymph Node, Mesenteric (15) (15) (14) (14) Hyperplasia, Lymphoid 1 (7%) Necrosis, Lymphoid 1 (7%) Spleen (15) (15) (15) (15) Atrophy 1 (7%) 1 (7%) 1 (7%) 2 (13%) Hematopoietic Cell Proliferation 2 (13%) 3 (20%) 1 (7%) 4 (27%) Necrosis 1 (7%) Thymus (15) (15) (15) (15) Atrophy 3 (20%) 3 (20%) 3 (20%) 4 (27%) Cyst 1 (7%) Thymocyte, Necrosis 2 (13%) 2 (13%) ____________________________________________________________________________________________________________________________________ a Number of animals examined microscopically at site and number of animals with lesion Page 3 NTP Experiment-Test: 97013-09 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03 Study Type: SUBCHRON 26-WEEK WATER DISINFECTION MODEL (SODIUM BROMATE) Date: 06/18/04 Route: DOSED WATER Time: 11:02:42 ____________________________________________________________________________________________________________________________________ TGAC (FVB/N) HEMIZYGOUS FEMALE 0 MG/L 80 MG/L 400 MG/L 800 MG/L ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM Skin (6) (5) (2) (7) Epidermis, Hyperkeratosis 2 (29%) Epidermis, Hyperplasia, Focal 2 (29%) Subcutaneous Tissue, Edema 1 (20%) ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM Lung (15) (15) (15) (15) Hemorrhage 1 (7%) Inflammation, Chronic Active 3 (20%) 1 (7%) ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM Kidney (15) (15) (15) (15) Mineralization 1 (7%) Nephropathy 2 (13%) 2 (13%) 10 (67%) 13 (87%) Artery, Inflammation, Chronic 2 (13%) Renal Tubule, Degeneration 2 (13%) 8 (53%) Renal Tubule, Dilatation 1 (7%) 2 (13%) 1 (7%) Renal Tubule, Hypertrophy 1 (7%) 5 (33%) 12 (80%) Renal Tubule, Necrosis 1 (7%) a Number of animals examined microscopically at site and number of animals with lesion Page 4 NTP Experiment-Test: 97013-09 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03 Study Type: SUBCHRON 26-WEEK WATER DISINFECTION MODEL (SODIUM BROMATE) Date: 06/18/04 Route: DOSED WATER Time: 11:02:42 ____________________________________________________________________________________________________________________________________ TGAC (FVB/N) HEMIZYGOUS MALE 0 MG/L 80 MG/L 400 MG/L 800 MG/L ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially In Study 15 15 15 15 Early Deaths Natural Death 2 2 1 Moribund Sacrifice 1 Survivors Terminal Sacrifice 13 13 14 14 Animals Examined Microscopically 15 15 15 15 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM Liver (15) (15) (15) (15) Inflammation, Chronic Active 9 (60%) 4 (27%) 10 (67%) 7 (47%) Necrosis 1 (7%) Hepatocyte, Vacuolization Cytoplasmic 6 (40%) 4 (27%) 7 (47%) 4 (27%) Mesentery (1) (1) Fat, Fibrosis 1 (100%) Fat, Inflammation, Chronic 1 (100%) Fat, Necrosis 1 (100%) Stomach, Forestomach (15) (15) (15) (15) Epithelium, Hyperkeratosis 1 (7%) 1 (7%) 2 (13%) Epithelium, Hyperplasia 1 (7%) 1 (7%) 2 (13%) 2 (13%) ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM Adrenal Cortex (15) (15) (15) (15) Hypertrophy 4 (27%) 6 (40%) 6 (40%) 4 (27%) Subcapsular, Hyperplasia 1 (7%) 1 (7%) 1 (7%) Parathyroid Gland (1) (2) Cyst 1 (100%) 2 (100%) Pituitary Gland (15) (14) (15) (15) Pars Distalis, Cyst 4 (27%) Thyroid Gland (15) (14) (15) (15) Infiltration Cellular, Lymphocyte 1 (7%) 1 (7%) 2 (13%) Follicle, Depletion Secretory 4 (27%) 6 (43%) 15 (100%) 15 (100%) a Number of animals examined microscopically at site and number of animals with lesion Page 5 NTP Experiment-Test: 97013-09 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03 Study Type: SUBCHRON 26-WEEK WATER DISINFECTION MODEL (SODIUM BROMATE) Date: 06/18/04 Route: DOSED WATER Time: 11:02:42 ____________________________________________________________________________________________________________________________________ TGAC (FVB/N) HEMIZYGOUS MALE 0 MG/L 80 MG/L 400 MG/L 800 MG/L ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM - CONT Follicular Cell, Hypertrophy 1 (7%) 2 (14%) 12 (80%) 15 (100%) ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM Epididymis (15) (15) (15) (15) Degeneration 2 (13%) 2 (13%) Preputial Gland (1) (1) Duct, Ectasia 1 (100%) 1 (100%) Testes (15) (15) (15) (15) Cyst 3 (20%) Germinal Epithelium, Degeneration 1 (7%) 3 (20%) 2 (13%) ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM Lymph Node (1) Mediastinal, Necrosis, Lymphoid 1 (100%) Lymph Node, Mandibular (15) (15) (15) (15) Hyperplasia, Lymphoid 3 (20%) 1 (7%) 3 (20%) 1 (7%) Necrosis, Lymphoid 1 (7%) Lymph Node, Mesenteric (15) (15) (15) (15) Necrosis, Lymphoid 1 (7%) Spleen (15) (15) (15) (15) Atrophy 1 (7%) 1 (7%) 1 (7%) Hematopoietic Cell Proliferation 1 (7%) 3 (20%) Lymphoid Follicle, Necrosis, Lymphoid 1 (7%) Thymus (15) (15) (14) (15) Atrophy 2 (13%) 1 (7%) 1 (7%) 2 (13%) Cyst 2 (13%) Ectopic Parathyroid Gland 1 (7%) Thymocyte, Necrosis 1 (7%) ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM Skin (2) (4) (3) Epidermis, Hyperkeratosis 1 (33%) a Number of animals examined microscopically at site and number of animals with lesion Page 6 NTP Experiment-Test: 97013-09 INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a) Report: PEIRPT03 Study Type: SUBCHRON 26-WEEK WATER DISINFECTION MODEL (SODIUM BROMATE) Date: 06/18/04 Route: DOSED WATER Time: 11:02:42 ____________________________________________________________________________________________________________________________________ TGAC (FVB/N) HEMIZYGOUS MALE 0 MG/L 80 MG/L 400 MG/L 800 MG/L ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM - CONT Epidermis, Hyperplasia, Focal 1 (25%) 2 (67%) ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM Lung (15) (15) (15) (15) Inflammation, Chronic Active 1 (7%) ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM Kidney (15) (15) (15) (15) Mineralization 1 (7%) Nephropathy 1 (7%) 7 (47%) 10 (67%) 14 (93%) Renal Tubule, Degeneration 10 (67%) Renal Tubule, Dilatation 1 (7%) Renal Tubule, Hypertrophy 2 (13%) a Number of animals examined microscopically at site and number of animals with lesion Page 7 ------------------------------------------------------------ ---------- END OF REPORT ---------- ------------------------------------------------------------